MYO16 and urinary bladder carcinoma: FAM13A-AS1 is a novel biomarker for the prognosis of thyroid cancer,38 and MYO16-AS1 acts as an oncogenic lncRNA in bladder cancer,39 AC007278.2 and RP11–153M7.5 are associated with SLE.40